Insilico Medicine Completes First Patient First Dose in BETHESDA: A Phase II Trial for Garutadustat (ISM5411), the Gut-restricted AI-driven PHD Inhibitor for the Treatment of ...

Insilico Medicine ("Insilico"), a clinical-stage, generative AI-driven drug discovery company, today announced the ...
IEEE

Interleaved Chirp Spreading LoRa-Based Modulation With Continuous Phase

Abstract: Exploration for new dimensions to convey information is a non-trivial task for resource-limited communications. Interleaved Chirp Spreading LoRa (ICS-LoRa) constitutes a new ...
IEEE

Discontinuous Pulse-Width Modulation With Balanced DC-Link Capacitor Voltages for Three-Phase Four-Level Inverters

Abstract: Compared with three-level inverters, four-level inverters need more switching times to balance the dc-link capacitor voltages, lowering the efficiency. This article proposes a four-level ...

New wireless standard: Wi-Fi 8 offers relief from congestion

Even though it will likely be another year until the adoption of Wi-Fi 8, also known as IEEE 802.11bn, first router ...

Addex Therapeutics: Addex Spin-Out Neurosterix has started a Phase 1 Clinical Study with M4 PAM - NTX-253 for Schizophrenia

Ad Hoc Announcement Pursuant to Art.?53 LR Geneva, Switzerland, January 7, 2026 - Addex Therapeutics(SIX: ADXN and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing ...

Cumulus Neuroscience Publishes Data Validating a Scalable Measurement of Neuroplasticity Using Low-Burden Dry Sensor EEG

Cumulus Neuroscience, a leading innovator in brain health technology for clinical trials, today announced the publication of its latest peer-reviewed paper in Scientific Reports: "A brief visual ...